Relmada Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $274k | 39k | 6.98 |
| 2025-03-31 | $43 | 158 | 0.27 |
| 2024-12-31 | $20k | 38k | 0.52 |
| 2024-09-30 | $1.0M | 315k | 3.24 |
| 2024-06-30 | $1.1M | 353k | 3.00 |
| 2024-03-31 | $818k | 176k | 4.65 |
| 2023-12-31 | $78k | 19k | 4.14 |
| 2023-09-30 | $2.6k | 859 | 3.00 |
| 2023-06-30 | $2.1k | 859 | 2.46 |
| 2023-03-31 | $47k | 21k | 2.24 |
| 2022-12-31 | $54k | 16k | 3.48 |
| 2022-06-30 | $351k | 16k | 21.98 |
| 2022-03-31 | $421k | 16k | 26.58 |
| 2021-12-31 | $167k | 7.4k | 22.54 |
| 2021-03-31 | $324k | 9.2k | 35.19 |
| 2020-12-31 | $261k | 8.1k | 32.28 |
| 2020-09-30 | $263k | 7.0k | 37.71 |
| 2020-06-30 | $277k | 6.2k | 44.83 |